PharmAbcine develops human therapeutic monoclonal antibody.
Business Model:
Revenue: $14.2M
Employees: 51-200
Address: 461-8, Daejeon BioventureTown, Jeonmin-Dong, Yuseong-Gu,
City: Daejeon
State: daejeon gwang'yeogsi
Zip: 300-000
Country: KR
PharmAbcine develops human therapeutic monoclonal antibody.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2009 | Unattributed | $6M |
Novartis Venture Fund OrbiMed Advisors |
9/2009 | Series A | 4 | $6M |
Green Cross OrbiMed Novartis Venture Fund Tong Yang Venture Capital Novartis Venture Fund OrbiMed OrbiMed Green Cross Novartis Venture Fund Tong Yang Venture Capital Novartis Venture Fund OrbiMed |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|